Home › NCT03667599
A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
Recruiting
A Randomized Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
Who can join
Ages 18 to 80 · All sexes
Full eligibility criteria
Patient Inclusion Criteria: * Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness * Age 18-80 years * Karnofsky Performance Scale KPS\> 80 * Able to read/write English * A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke Patient Exclusion Criteria: * Lack of a caregiver * Pregnant women * Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection. * Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota Caregiver Inclusion Criteria: * Identified by patient as their primary caregiver * Meet standard clinical criteria for being a caregiver (able to drive and take care of patient) * Age 18-80 years Caregiver Exclusion Criteria: None
About the study
This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.
What is being tested
- home care (other)
Sponsor: Duke University · Participants: 150 · Started: Sep 28, 2018
Contact the study team
- Andrea Pires, MS · Phone: 919-613-1546
Official record on ClinicalTrials.gov — NCT03667599
Locations in the U.S.
| North Carolina | Duke University Medical Center, Durham |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.